Integrative Strategies for Understanding Neural and Cognitive Systems (NCS)
Letter of Intent Deadline Date: December 15, 2022 Required only for FRONTIERS proposals, FY 2023 competition Program Guidelines: NSF 21-517The complexities of brain and behavior pose fundamental questions in many areas of science and engineering, drawing intense interest across a broad spectrum of disciplinary perspectives while eluding explanation by any one of them. Rapid advances within and across disciplines are leading to an increasingly interwoven fabric of theories, models, empirical methods and findings, and educational approaches, opening new opportunities to understand complex aspects of neural and cognitive syst...
Source: NSF Upcoming Due Dates - November 15, 2022 Category: Science Source Type: funding
Notice of Change to Key Dates and Review Locus for RFA-NS-19-043 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Notice NOT-NS-23-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 10, 2022 Category: Research Source Type: funding
Notice of Change to Key Dates and Review Locus for RFA-NS-19-044 "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)"
Notice NOT-NS-23-040 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 10, 2022 Category: Research Source Type: funding
Investigating the Effects of Addictive Substances on Brain Developmental Trajectories Using Innovative Scalable Methods for Quantification of Cell Identity, Lineage and Connectivity (R01 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-036 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support projects that investigate the effects of addictive substances on developmental trajectories of molecularly-defined CNS cells and circuits. Emphasis is on carrying out systematic and highly granular quantitative characterizations of the impact of in utero and/or postnatal substance exposure on the numbers, spatial distribution and connectivity of molecularly-defined cells, across whole brains or within distributed circuits of clinical relevance. The ultimate goals of the program are to i...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2022 Category: Research Source Type: funding
Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-24-004 from the NIH Guide for Grants and Contracts. The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat ne...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2022 Category: Research Source Type: funding
